Christophe von Garnier

University of Lausanne — Switzerland

Medicine · Health Sciences

40h-index6.4kcitations339works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(52), Chronic Obstructive Pulmonary Disease (COPD) Research(48), Inhalation and Respiratory Drug Delivery(43), Immunotherapy and Immune Responses(39), Lung Cancer Diagnosis and Treatment(26)

Publications336 total

Respiratory and Gut Microbiota Correlate with Lung Function Recovery after Severe COVID-19
2026Open Access
Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry
Biomedicines·2025Open Access
Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry.
Open Access CRIS of the University of Bern·2025Open Access
Association Between Exertional Dyspnea and OSA
CHEST Journal·2025Open Access
Prevalence and Environmental Correlates of Small Airways Dysfunction in a Rural Swiss Cohort
Respiration·2025Open Access
P1.04.03 Comorbidities and Social Factors in Lung Cancer Screening Eligibility: Insights From the Colaus and Lc65 Cohorts in Switzerland
Journal of Thoracic Oncology·2025
P1.04.15 Lung Cancer Screening in Switzerland: Baseline Results From the Vaud Pilot Project
Journal of Thoracic Oncology·2025
Association between BRINDA-corrected iron metabolism and lung function in the community: the CoLaus|PneumoLaus study
BMC Pulmonary Medicine·2025Open Access
Fibrotic patterns on chest CT following severe SARS-CoV-2 infection are associated with alterations in airway and gut microbiota composition
2025
Respiratory tract mycobiota profiles and bacterial-fungal co-occurrence after severe COVID-19 are associated with lung function
2025
The effect of biologics in the treatment of severe asthma- analysis of an age and sex matched cohort
2025
Neonatal lung dysbiosis models to investigate mucosal allergic priming
2025
Environmental interference in the fight against respiratory Aspergillus infection
2025
Microbiome as a predictor of long-term pulmonary outcomes in severe SARS-CoV-2 survivors
2025
Optimizing early lung cancer detection in Switzerland: Preliminary insights from the Vaud Lung Cancer Screening Pilot Project
Lung Cancer·2025
Modulation of allergic airways disease employing bio-mimetic nanoparticles with TLR agonists
Frontiers in Allergy·2025· 2 citedOpen Access
Chimeric Allergen Receptor regulatory T cells suppress birch pollen allergic airway inflammation.
2025Open Access
A statistical model for tuberculosis diagnosis to guide multi-test strategies and clinical decision-making
2025Open Access
The Effect of Comorbidities on Asthma-Related Outcomes Over a Two-Year Period: A Prospective Analysis of Swiss Severe Asthma Registry (SSAR)
Journal of Asthma and Allergy·2025· 1 citedOpen Access
High mortality and violence among refugees and returnees from West Darfur, Sudan arriving in Chad, 2023: results from three retrospective mortality surveys
BMJ Global Health·2025Open Access
page 1 of 17Next →

Frequent Co-authors

Fabian Blank(12), Barbara Rothen‐Rutishauser(10), Alke Petri‐Fink(9), Patrick G. Holt(6), Laura Rodríguez‐Lorenzo(6), Philip A. Stumbles(5), Laurent Nicod(5), Emilie Seydoux(5), Kleanthis Fytianos(5), Thomas Geiser(4), Christian Garzoni(4), Deborah H. Strickland(4), Benjamin J. Marsland(4), Grégory Giuliani(4), Roland Bingisser(3), Pierre‐Olivier Bridevaux(3), Christian F. Clarenbach(3), Sebastian R. Ott(3), Manuela Funke-Chambour(3), Matthew E. Wikström(3)